Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® Spray, 0.05%, as well as rights to market and distribute TRIANEX® 0.05% and PROMISEB® Topical Cream in the United States from Dr. Reddy’s Laboratories Ltd., through its wholly owned subsidiary Promius Pharma LLC.
Bob Moccia, Encore Dermatology President and CEO, states: “We are very excited about the opportunity to acquire such a great portfolio of products. This acquisition allows Encore to expand our portfolio of innovative medical dermatology products and better partner with our dermatology customers to successfully treat skin diseases such as psoriasis, atopic dermatitis and acne. We look forward to working with the Promius team to ensure a smooth transition of the assets so we are able to quickly deliver these products to providers and patients.”
Encore Dermatology is expanding through acquisitions, in-licensing and co-marketing opportunities.
Date: April 08, 2019
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Yahoo Finance